Accueil › Myélome multiple › District de Columbia › Washington
Essais cliniques pour Myélome multiple à Washington, DC
22 études pour Myélome multiple recherchent des participants dans et autour de Washington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Recrutement en coursPhase 1
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Recrutement en coursPhase 3
- Research Site, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Recrutement en coursPhase 2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Tissue Collection for Studies of Lymph Cancer
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Recrutement en coursPhase 4
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · à 7 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Recrutement en coursPhase 3
- Center for Cancer and Blood Disorders, Bethesda · à 7 mi
18F-Fluciclovine PET/CT in Multiple Myeloma
Recrutement en coursPhase 2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Recrutement en coursPhase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · à 7 mi
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Recrutement en coursPhase 2
- Lombardi Comprehensive Cancer Center, Washington D.C.
Collection of Tissue Samples for Cancer Research
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Recrutement en coursPhase 3
- Georgetown University Medical Center, Washington D.C.
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Recrutement en coursPhase 3
- MedStar Washington Hospital Center MedStar Georgetown Cancer Institute, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Recrutement en coursPhase 2
- GSK Investigational Site, Bethesda · à 7 mi
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Recrutement en coursPhase 3
- Sibley Memorial Hospital, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
Recrutement en cours
- Georgetown University School of Medicine, Washington D.C.
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Recrutement en coursPhase 1
- Maryland Oncology Hematology - Silver Spring /ID# 268562, Silver Spring · à 7 mi
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Recrutement en coursPhase 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · à 7 mi
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Recrutement en coursPhase 3
- Sibley Memorial Hospital, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Recrutement en coursPhase 3
- GSK Investigational Site, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Recrutement en coursPhase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Essais pour Myélome multiple dans d'autres villes
- New York City, NY60 études
- Boston, MA42 études
- Atlanta, GA42 études
- Houston, TX38 études
- Durham, NC37 études
- Nashville, TN32 études
- Denver, CO27 études
- Rochester, MN24 études
- St. Louis, MO24 études
- Columbus, OH24 études
- Baldwin Park, CA23 études
- Edison, NJ22 études
Autres études à Washington
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules55 études
- Cancer du sein46 études
- Cancer métastatique43 études
- Cancer du poumon41 études
- Cancer de la prostate38 études
- Obésité33 études
- Cancer colorectal29 études
- Maladie cardiovasculaire28 études
- Cancer de la vessie26 études
- Leucémie aiguë myéloïde24 études
- Cancer de l'ovaire23 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.